Trust Co. of Vermont Invests $1.12 Million in The Clorox Company $CLX

Trust Co. of Vermont bought a new stake in The Clorox Company (NYSE:CLX - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 11,753 shares of the company's stock, valued at approximately $1,122,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Clorox by 4.0% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company's stock worth $1,970,000 after buying an additional 514 shares during the last quarter. Woodline Partners LP grew its holdings in shares of Clorox by 253.7% in the first quarter. Woodline Partners LP now owns 10,407 shares of the company's stock valued at $1,532,000 after acquiring an additional 7,465 shares in the last quarter. Baird Financial Group Inc. increased its position in shares of Clorox by 1.7% during the second quarter. Baird Financial Group Inc. now owns 25,032 shares of the company's stock valued at $3,006,000 after acquiring an additional 424 shares during the last quarter. Jump Financial LLC lifted its holdings in Clorox by 173.5% during the second quarter. Jump Financial LLC now owns 12,491 shares of the company's stock worth $1,500,000 after acquiring an additional 7,924 shares during the period. Finally, Bank of Nova Scotia lifted its holdings in Clorox by 26.2% during the second quarter. Bank of Nova Scotia now owns 16,141 shares of the company's stock worth $1,938,000 after acquiring an additional 3,352 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Trading Down 0.1%

Shares of CLX opened at $105.86 on Wednesday. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $128.90. The business has a 50-day moving average of $98.44 and a 200 day moving average of $103.17. The firm has a market cap of $12.80 billion, a P/E ratio of 21.96, a price-to-earnings-growth ratio of 3.15 and a beta of 0.54. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, topping analysts' consensus estimates of $1.64 by $0.02. The firm had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.91 billion. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The company's quarterly revenue was down 2.0% on a year-over-year basis. During the same quarter last year, the business earned $2.87 earnings per share. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, research analysts forecast that The Clorox Company will post 5.8 EPS for the current year.

Clorox Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 28th. Shareholders of record on Wednesday, August 12th will be given a dividend of $1.25 per share. This is an increase from Clorox's previous quarterly dividend of $1.24. This represents a $5.00 annualized dividend and a dividend yield of 4.7%. The ex-dividend date is Wednesday, August 12th. Clorox's dividend payout ratio (DPR) is currently 103.73%.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Barclays restated an "underweight" rating and issued a $84.00 price objective on shares of Clorox in a research note on Tuesday, August 4th. Jefferies Financial Group downgraded shares of Clorox from a "buy" rating to a "hold" rating and cut their price target for the stock from $125.00 to $98.00 in a report on Tuesday, July 28th. The Goldman Sachs Group restated a "sell" rating and set a $83.00 price target on shares of Clorox in a research report on Friday, May 1st. Zacks Research downgraded shares of Clorox from a "hold" rating to a "strong sell" rating in a report on Tuesday, May 12th. Finally, Wall Street Zen cut shares of Clorox from a "hold" rating to a "sell" rating in a research note on Saturday. Twelve equities research analysts have rated the stock with a Hold rating and five have given a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Reduce" and a consensus price target of $102.40.

More Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Zacks Research raised its EPS forecasts for Clorox’s third-quarter 2027 and fourth-quarter 2027, and projects earnings of $6.89 per share for fiscal 2029. These increases suggest some potential for longer-term earnings growth, although they were offset by reductions elsewhere.
• Neutral Sentiment: An analysis comparing Church & Dwight (CHD) and Clorox (CLX) highlights Clorox’s higher dividend yield. However, Clorox has increased its dividend more cautiously, making the stock more attractive to current-income investors than to investors seeking rapid dividend growth. Two Consumer Staples, Two Dividend Strategies: Church & Dwight and The Clorox Company
• Negative Sentiment: A cyclospora outbreak has made consumers more cautious about buying salads, and one analyst reportedly sees declining sales for Clorox’s Hidden Valley Ranch dressing. A sustained pullback in salad consumption could weigh on brand sales and near-term revenue. Hidden Valley Ranch dressing may be a victim of this summer’s salad scare
• Negative Sentiment: Zacks Research lowered its fiscal 2027 EPS estimate to $5.82 from $6.00 and cut its fiscal 2028 forecast to $6.23 from $6.36. It also reduced estimates for the first and second quarters of fiscal 2028 and the second quarter of fiscal 2027. The firm maintains a Strong Sell rating, which is a notable negative signal despite several upward revisions.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source